PATENT CLAIM ANALYSIS

Application Number: 15979287
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "575000"]

Abstract:
The invention relates generally to the treatment of multiple myeloma. One embodiment of the invention provides a method of treating multiple myeloma (MM) in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).

Claim (Index 5):
The method of  claim 2 , wherein the effective amount is an amount sufficient to decrease expression of each of CCNB1, AURKB, CDC2, BIRC5, KIF11, KIF2C, TOP2A, ASPM, CKS1B, and WEE1.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13819963', '11133937', '15593937', '13899196', '14417332']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7733185010162934
- 35 USC 102 Novelty (BERT): 0.5194113648851736
- Combined Prediction Score: 0.7479277874031814
- Mean Citation Score: 219.458936
- Max Citation Score: 245.81374
- Similarity Product: 133.08174580682154

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test